CINC

CinCor Pharma, Inc. Common Stock

Delisted

CINC was delisted on the 23rd of February, 2023.

57 hedge funds and large institutions have $596M invested in CinCor Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.1M
2 +$9.18M
3 +$3.56M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.32M
5
BlackRock
BlackRock
New York
+$3.13M

Top Sellers

1 -$1.71M
2 -$1.32M
3 -$740K
4
PHK
Point72 Hong Kong
Hong Kong
-$387K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$328K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$105M
2
$81.7M
3
$77.7M
4
$43.7M
5
$42.7M
6
$40.4M
7
$31M
8
$26.2M
9
$19.2M
10
$18.2M
11
$17.9M
12
$15.9M
13
$12.8M
14
$12.6M
15
$11.9M
16
$9.18M
17
$4.34M
18
$4.21M
19
$3.66M
20
$2.58M
21
$2.15M
22
$1.72M
23
$1.61M
24
$979K
25
$973K